Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
BOQI announced its wholly-owned subsidiary, Chongqing Guanzan Technology has entered into a $19 million medical device purchase agreement with Shandong Forward Medical.
read more
Monday, February 03, 2020
BOQI International Medical has entered into a stock purchase agreement to acquire Chongqing Guanzan Technology through its wholly-owned subsidiary Beijing Xin Rong Xin Industrial Development.
read more
Bora Pharmaceuticals announced that due to continued growth in demand for its drug product services, it plans to add further sterile fill/finish capacity at its facility in Baltimore, Maryland.
read more
Bora has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
Bora Pharmaceuticals has announced the appointment of four business development directors to its commercial teams in the US and Taiwan.
read more
Monday, November 25, 2019
Bora has announced the appointment of Sam Ricchezza as President of North American operations.
read more
Wednesday, December 04, 2019
Bora has announced the appointment of Samuel Ricchezza as President of North America Operations.
read more
Monday, September 25, 2023
Bora Health, a global design, development and distribution partner of pharmaceuticals and health foods and part of the Bora group, has announced its collaboration with Sunway Biotech, a leading ingredients manufacturer, and research and development (...
read more
Tuesday, December 15, 2020
Bora announced the CDMO has successfully completed the acquisition of GSK’s Mississauga, Ontario facility.
read more
Wednesday, August 21, 2024
Bora Pharmaceuticals Co., Ltd. announced that it has completed the acquisition from Emergent BioSolutions of its sterile manufacturing facility in Baltimore-Camden, Maryland. The facility adds drug product fill/finish to Bora’s extensive biologics ...
read more
Thursday, September 15, 2022
Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of TWi Pharmaceutical Co.Ltd, a technology-based company specializing in development and commercialization of niche generic ...
read more
Bora has announced the opening of its first North American office in Delaware, U.S.
read more
Taiwan-based contract development and manufacturing organization (CDMO) Bora Pharmaceuticals has announced the establishment of Bora Biologics Co., Ltd., a CDMO platform for biologics.
read more
Bora Pharmaceuticals Co., Ltd. announced that it has completed the acquisition of Upsher-Smith Laboratories, a generics manufacturer and marketer based in Minnesota, U.S., from its sellers, Sawai Group Holdings and Sumitomo Corporation of Americas.
read more
Bora Pharmaceuticals has installed a high-performance filling line from Norden Machinery at its Mississauga, Ontario manufacturing facility. The new line expands Bora’s production capabilities, enabling larger volumes at higher speeds with greater ...
read more